SG Americas Securities
MESO

SG Americas Securities’s Mesoblast MESO Stock Holding History

SG Americas Securities’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,000
Closed -$114K – 3146
2020
Q2 		$114K Buy
+5,000
New +$107K ﹤0.01% 3289

Other funds holding MESO

MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAMG
Odey Asset Management Group London, United Kingdom $381M AUM 45.36% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SG Americas Securities's MESO Position: Q3 2020 in Review

SG Americas Securities sold out of Mesoblast (MESO) in Q3 2020, closing a stake of 5,000 shares — an estimated $114K sold.

SG Americas Securities first reported a position in MESO in Q2 2020 and held it in 1 quarter. The position peaked at $114K in Q2 2020. 52 funds tracked by Wall St. Rank hold MESO as of Q3 2020.

  • SG Americas Securities reported no remaining Mesoblast position as of Q3 2020 after selling out during the quarter.
  • SG Americas Securities sold 5,000 Mesoblast shares in Q3 2020, an estimated $114K.
  • SG Americas Securities first reported a position in Mesoblast in Q2 2020 and held it in 1 quarter.
  • SG Americas Securities's Mesoblast position peaked at $114K in Q2 2020.
  • 52 funds tracked by Wall St. Rank held Mesoblast as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.